Rachel Gross, M.D.
Rheumatology Physician in Plymouth, Massachusetts.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 6,200 in Rheumatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Rachel Gross, M.D. filed 4,606 Medicare Part D claims in 2023 as a Rheumatology Physician in Plymouth, Massachusetts, prescribing 78% generic.
- 5K
- Part D claims, 2023
- 78%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Rachel Gross, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
4,606 Top 7% higher than 93% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
Rachel Gross, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Rachel Gross, M.D.?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Massachusetts
How Rheumatology Physician compares to other specialties among Massachusetts providers
Rheumatology Physician ranks #95 among Massachusetts's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the Massachusetts provider total, by primary NUCC taxonomy. The highlighted bar is Rheumatology Physician; the long tail of smaller specialties is omitted for legibility.
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Rheumatology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Rachel Gross, M.D. appears in the CMS NPPES registry as a Rheumatology Physician provider holding M.D. credentials at 110 LONG POND RD, Plymouth, MA, 02360, with a listed phone of (508) 746-5351. NPI 1811157522 was issued on 06/16/2008.
Medicare Part D records for calendar year 2023 show 4,606 prescription claims written by this provider, covering 685 Medicare beneficiaries and totaling roughly $6.1 million in drug spend, split 22% brand-name and 78% generic by claim count, with an opioid prescribing rate of 3.9%.
Rheumatology Physician is a mid-sized specialty nationwide, with 6,200 enrolled providers across 52 states and an average of 2,054 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1811157522 |
|---|---|
| Specialty | Rheumatology Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 06/16/2008 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Rachel Gross, M.D.'s current license status, disciplinary history, and board certifications with the Massachusetts Board of Registration in Medicine in Massachusetts before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1811157522 is the unique 10-digit identifier CMS uses to link Gross across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
Hospital and facility affiliations
Facilities where Rachel Gross, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Rachel Gross, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$15
Largest payer
Sandoz Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Massachusetts BORIM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 - they are NOT specific to Rachel Gross, M.D.. To verify Rachel Gross, M.D.'s current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
22% brand-name claims vs 78% generic, on 4,606 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 8,201
- Total Day Supply
- 239,149
- Brand vs Generic
- 22% brand / 78% generic
- Brand Drug Cost
- $6.0M
- Generic Drug Cost
- $131K
- Opioid Claims
- 178 (3.9% rate)
Patient Demographics
- Average Patient Age
- 73.0 years
- Avg HCC Risk Score
- 1.59
- Gender Split
- 69% female / 31% male
- Age Distribution
- <65: 79, 65-74: 283, 75-84: 272, 85+: 51
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Rachel Gross, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Methotrexate
Methotrexate
725 claims
- Prednisone
Prednisone
688 claims
- Hydroxychloroquine…
Hydroxychloroquine Sulfate
468 claims
- Allopurinol
Allopurinol
299 claims
- Humira(Cf) Pen 246
Humira(Cf) Pen
246 claims
- Alendronate Sodium 192
Alendronate Sodium
192 claims
- Gabapentin 140
Gabapentin
140 claims
- Tramadol Hcl 139
Tramadol Hcl
139 claims
| Drug | Claims |
|---|---|
| Methotrexate Methotrexate Sodium | 725 |
| Prednisone | 688 |
| Hydroxychloroquine Sulfate | 468 |
| Allopurinol | 299 |
| Humira(Cf) Pen Adalimumab | 246 |
| Alendronate Sodium | 192 |
| Gabapentin | 140 |
| Tramadol Hcl | 139 |
| Leflunomide | 133 |
| Otezla Apremilast | 76 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Rheumatology Physician Overview
How Rachel Gross, M.D. fits within the Rheumatology Physician landscape nationally.
Rachel Gross, M.D.'s 4,606 claims are above the specialty average of 2,054.
Nearby Rheumatology Physician Providers in Massachusetts
Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as Gross.
Compare Rheumatology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Massachusetts medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Rheumatology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Massachusetts
Frequently Asked Questions
What is Rachel Gross, M.D.'s specialty? ▼
How much does Rachel Gross, M.D. prescribe under Medicare Part D? ▼
Where is Rachel Gross, M.D. located? ▼
What is Rachel Gross, M.D.'s NPI number? ▼
Does Rachel Gross, M.D. prescribe more brand-name or generic drugs? ▼
Does Rachel Gross, M.D. prescribe opioids? ▼
How many Rheumatology Physician providers are there in the US? ▼
What drugs does Rachel Gross, M.D. prescribe most often? ▼
Does Rachel Gross, M.D. accept Medicare? ▼
How can I verify Rachel Gross, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor Editorial
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.